Furthermore, elevated phosphorylated STAT3 promotes trastuzumab resistance in human epidermal growth factor receptor 2 (HER2)-overexpressing BC cells by upregulating HIF-1α levels and downregulating PTEN [51]. This evidence concerns the gene ERBB2 and breast cancer.